Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Indian J Dermatol Venereol Leprol. 2003 May-Jun;69(3):209-11.

    Diltiazem vs. nifedipine in chilblains: a clinical trial.

    Source

    Department of Dermatology, STD &Leprosy, Military Hospital, Agra, India, India.

    Abstract

    BACKGROUND:

    The treatment of chilblains remains unsatisfactory. Nifedipine in higher doses remains the mainstay of treatment.

    AIMS:

    To compare the efficacy of diltiazem with that of nifedipine, and to determine the efficacy of nifedipine in lower doses, 36 chilblains cases were studied.

    MATERIAL AND METHODS:

    Group A (12 patients) was treated with diltiazem 60 mg thrice daily, and Group B (24 patients) with 10 mg nifedipine thrice daily till complete relief and then maintained on a sustained release preparation of nifedipine 20 mg twice daily.

    RESULTS:

    Two patients in Group A showed complete relief in 7 days, and 3 patients in about 21 days, but in 7 cases there was little or no response. In group B, 21 cases showed 80-90% relief by the fourteenth day.

    CONCLUSIONS:

    We conclude that nifedipine remains the drug of choice in chilblains but can be used in a smaller dosage in the Indian population. Diltiazem is less effective in the conventional dose, which may be optimized.

    PMID:
    17642888
    [PubMed]
    Free full text

      Supplemental Content

      Icon for Medknow Publications and Media Pvt Ltd

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk